Genygi Life Sciences
  • Products
  • News
  • About Us
  • Contacts
Genygi Life Sciences
Menu

Oncology

Categories
  • Oncology
  • Hepatitis B
  • Hepatitis C
Главная страница » Oncology » Page 2

Showing 13–24 of 25 results

Show sidebar
Show 9 12 18 24
LENALIDOMIDE-Lenagen-25
LENALIDOMIDE-Lenagen-25
Read more

Lenagen-25

Oncology
LENVATINIB - Lenvagen 10
Read more

Lenvagen-10

Oncology
LENVATINIB - Lenvagen 4
Read more

Lenvagen-4

Oncology
OLAPARIB - Olapragen 150 mg
OLAPARIB - Olapragen 150 mg
Read more

Olapragen-150

Oncology
Read more

Palgyra-125

Oncology
Pazogen-200
Pazogen-200
Read more

Pazogen-200

Oncology
POMALIDOMIDE - Pomagen 1
Read more

Pomagen-1

Oncology
POMALIDOMIDE - Pomagen 2
Read more

Pomagen-2

Oncology
Sorafgen-200
SORAFGEN-200 (BOTTLE)
Read more

Sorafgen-200

Oncology
SunitiGen
SUNITUGEN-25
Read more

Sunitigen-25

Oncology
Sunitigen-50
Read more

Sunitigen-50

Oncology
TAMOXIFEN - Tamoxelle 20
Read more

Tamoxelle 20

Oncology
  • ←
  • 1
  • 2
  • 3
  • →
Disclaimer:

This medical information is intended exclusively for healthcare professionals in India. The products discussed herein may have different labeling and regulatory requirements in other countries.

The information provided on this site is scientific, evidence-based, and intended to address unsolicited medical inquiries in a balanced manner.

For full Prescribing Information, including indications, contraindications, warnings, precautions, and potential adverse events, please submit a medical information request.

This content is not intended as medical advice. Responsibility for patient care rests solely with the healthcare professional, based on their professional license, expertise, and knowledge of the patient.

This website does not engage in the sale or purchase of any medicines.

Genygi Life Sciences Private Limited

  • Catalog
  • Certificate
  • Contacts
  • Privacy Policy
Copyright 2025 GENYGI
  • Products
  • News
  • About Us
  • Contacts
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
More info More info Accept